- Research article
- Open Access
Salmonella Typhimurium ST213 is associated with two types of IncA/C plasmids carrying multiple resistance determinants
© Wiesner et al; licensee BioMed Central Ltd. 2011
- Received: 10 September 2010
- Accepted: 11 January 2011
- Published: 11 January 2011
Salmonella Typhimurium ST213 was first detected in the Mexican Typhimurium population in 2001. It is associated with a multi-drug resistance phenotype and a plasmid-borne blaCMY-2 gene conferring resistance to extended-spectrum cephalosporins. The objective of the current study was to examine the association between the ST213 genotype and blaCMY-2 plasmids.
The blaCMY-2 gene was carried by an IncA/C plasmid. ST213 strains lacking the blaCMY-2 gene carried a different IncA/C plasmid. PCR analysis of seven DNA regions distributed throughout the plasmids showed that these IncA/C plasmids were related, but the presence and absence of DNA stretches produced two divergent types I and II. A class 1 integron (dfrA12, orfF and aadA2) was detected in most of the type I plasmids. Type I contained all the plasmids carrying the blaCMY-2 gene and a subset of plasmids lacking blaCMY-2. Type II included all of the remaining blaCMY-2-negative plasmids. A sequence comparison of the seven DNA regions showed that both types were closely related to IncA/C plasmids found in Escherichia, Salmonella, Yersinia, Photobacterium, Vibrio and Aeromonas. Analysis of our Typhimurium strains showed that the region containing the blaCMY-2 gene is inserted between traA and traC as a single copy, like in the E. coli plasmid pAR060302. The floR allele was identical to that of Newport pSN254, suggesting a mosaic pattern of ancestry with plasmids from other Salmonella serovars and E. coli. Only one of the tested strains was able to conjugate the IncA/C plasmid at very low frequencies (10-7 to 10-9). The lack of conjugation ability of our IncA/C plasmids agrees with the clonal dissemination trend suggested by the chromosomal backgrounds and plasmid pattern associations.
The ecological success of the newly emerging Typhimurium ST213 genotype in Mexico may be related to the carriage of IncA/C plasmids. We conclude that types I and II of IncA/C plasmids originated from a common ancestor and that the insertion and deletion of DNA stretches have shaped their evolutionary histories.
- Yersinia Pestis
- Plasmid Profile
- ST213 Strain
- ST213 Isolate
- PstI Restriction
A substantial amount of the genetic variation in bacteria is carried in plasmids . Plasmids are part of the flexible genome, which is defined by the high plasticity and modularity of its genetic elements and high rates of gene acquisition and loss . They are typically composed of conserved backbone modules coding for replication, maintenance and transfer functions as well as variable accessory modules. The capture of genetic modules by plasmid backbones can increase phenotypic diversity and thereby increase the chances of responding to uncertain environmental changes or of exploiting an opportunity for transient niche expansion [2, 3]. Plasmids are classified according to incompatibility (Inc) groups that are based on the inability of plasmids with the same replication or segregation mechanisms to co-exist in the same cell . IncA/C plasmids have attracted the attention of the research community due to their ability to acquire antimicrobial resistance traits and to mobilize them across geographical and taxonomical borders . Recent comparative studies have addressed the evolutionary relationships among the IncA/C plasmids from Salmonella enterica, Escherichia coli, Yersinia pestis, Yersinia ruckeri, Vibrio cholera, Photobacterium damselae and Aeromonas salmonicida [5–10]. Over the last decade, increasing attention has been focused on plasmids that harbour the antimicrobial resistance gene blaCMY-2, which encodes an AmpC-type beta-lactamase that hydrolyzes third-generation cephalosporins [11–13]. In Salmonella enterica, blaCMY-2 is frequently carried by IncA/C or IncI1 plasmids [11, 12, 14, 15].
In a previous study, we examined the genetic variation of a Salmonella enterica serovar Typhimurium population isolated from human and food-animal sources from four geographic regions in Mexico . Multilocus sequence typing (MLST) and XbaI macro-restriction showed two predominant genotypes, ST19 and ST213. ST19 has been reported worldwide and is the most abundant Typhimurium genotype in the MLST database , while ST213 has only been reported in Mexico. Clonal complex analysis supported ST19 as the founder genotype, while ST213 was determined to be a derived genotype replacing ST19. We found a non-random distribution of virulence and antimicrobial resistance accessory genes across chromosomal backgrounds, and several associations among core and accessory genetic markers were detected. First, the Salmonella virulence plasmid (pSTV) was found in ST19 strains, but not in ST213 strains. Second, the plasmid-borne blaCMY-2 gene was found only in ST213 strains. Third, the most abundant integron, the integron profile one (IP-1; dfrA12, orfF and aadA2), was found only in ST213 strains. Fourth, the Salmonella genomic island (SGI1) was found in a subgroup of ST19 strains carrying pSTV . The general picture obtained from that study was a population composed of two main genotypes marked by the presence of different accessory genes.
The emergence of the multi-drug resistant (MDR) ST213 genotype associated with resistance to expanded spectrum cephalosporins is a public health threat in Mexico where this clone has rapidly disseminated throughout certain regions, causing severe and fatal infections in infants . The objective of the current study was to examine the association between the recently emerged genotype MDR ST213 and blaCMY-2 plasmids. ST213 isolates were analyzed by plasmid profiling, PCR replicon typing , plasmid PstI restriction profiles [12, 20], Southern hybridization, plasmid PCR screening and sequencing of regions scattered throughout the IncA/C plasmids , and by their conjugation abilities. We found two divergent types of IncA/C plasmids: one composed of plasmids possessing or lacking the blaCMY-2 region and the other lacking blaCMY-2. We discuss our results in the context of epidemiological findings in Mexico, and we present evolutionary hypotheses regarding the origin of the two genetic types of IncA/C plasmids.
Plasmid profiling, PCR replicon typing and plasmid size
PCR replicon typing was performed for incompatibility groups that had been reported to be associated with either pSTV or blaCMY-2, such as IncFII, IncFIB, IncA/C, IncHI2 and IncI1 [14, 15, 21, 22]. All 36 isolates that carried blaCMY-2 were positive for the IncA/C group and negative for the other Inc groups. Unexpectedly, among the 32 ST213 isolates lacking blaCMY-2, 23 were positive for the IncA/C group. Additionally, the IncHI2 and IncI1 groups were detected in three and two isolates, respectively. Thirteen blaCMY-2-negative and IncA/C-positive isolates were selected to represent different sources, states and years of isolation for further analysis, and compared them with the blaCMY-2-positive isolates (hereafter referred to as CMY- and CMY+, respectively).
Characterization of IncA/C plasmids based on the antibiotic resistance phenotype
To isolate and characterize the IncA/C plasmids present in the Mexican ST213 genotype, E. coli TOP10 or DH5α transformants were obtained using plasmid DNA isolated from 32 CMY+ and 13 CMY- strains. Ceftriaxone was used to select CMY+ plasmids, and chloramphenicol was used to select CMY- plasmids because this resistance has been found to be part of the IncA/C plasmid backbone [5, 6, 8].
All the transformants carrying the IncA/C plasmids also displayed resistance to ampicillin, chloramphenicol, sulphonamides, streptomycin and tetracycline. Resistance to gentamicin was conferred by most of the CMY+ plasmids, and trimethoprim-sulfamethoxazol resistance was mostly detected in the plasmids containing the IP-1 integron (dfrA12, orfF and aadA2; see below). Resistance to neither kanamycin nor nalidixic acid was transferred (Figure 2). These results indicate that the MDR phenotypes of ST213 strains can be explained largely by the presence of IncA/C plasmids.
PstI restriction fingerprints
The plasmid profiles showed that all of the E. coli transformants carried one large plasmid of between 100 and 160 kb. These transformants were analyzed by PstI restriction fingerprinting [12, 23]. Cluster analysis of the PstI fingerprints showed two main plasmid types (similarity <50%), which we named type I and type II (Figure 2). All of the CMY+ plasmids were contained in type I and were distributed into three clusters (a, c and d). The CMY- plasmids were found in two distinct groups: one in type II and the other in cluster b within type I, suggesting that the CMY- plasmids originated from two divergent IncA/C plasmid types. To put our plasmids into context, IncA/C CMY+ reference plasmids from E. coli AR060302  and Newport SN11  were included. The restriction profiles of these plasmids were related to our ST213 type II plasmids, which in contrast were all CMY-.
We compared the sampling information (see Methods) and our previously generated genomic DNA XbaI macrorestriction patterns  with the plasmid PstI restriction patterns. The observed distribution of the plasmids among genomic backgrounds was consistent with a pattern of clonal spread. The most evident association was between XbaI cluster Ib and PstI cluster e; these isolates came from Sonora and were sampled in 2004-2005 (Figure 2).
PCR screening and nucleotide sequence analysis of the plasmids
Ten strains representing different geographic locations, years and sources were chosen and their regions analyzed in the PCR screening were sequenced (Additional file 2, Table S2). The sequences were identical for all the plasmids (both CMY+ and CMY-); only the mer region showed a single nucleotide substitution (Additional file 2, Table S2). It was surprising that even intergenic regions and third codon positions were invariable. BLAST searches showed that our sequences are identical (100% identity) to the IncA/C plasmids pAR060302 (E. coli), peH4H (E. coli), pAM04528 (Newport) and pSN254 (Newport); are closely related (99-98%) to the IncA/C plasmids pIP1202 (Yersinia pestis), pYR1 (Yersinia ruckeri), pP91278 (Photobacterium damselae), pP99-018 (P. damselae) and pMRV150 (Vibrio cholerae); and are related (88-89% identity) to pRA1 (Aeromonas hydrophila) [5–10]. The repA gene displays the repA/C 2 allele described for other IncA/C CMY+ plasmids . Call et al.  reported that one of the most variable parts of the IncA/C plasmids is the floR gene; the floR allele found in the ST213 isolates is identical to that of pSN254, which differs from that of pAR060302 by three non-synonymous substitutions. The traC-dsbC junction (PCR G) of the CMY island (Figure 4) was found in all the plasmids mentioned above and in the recently described integrating conjugative element ICEPmiJpn1 of Proteus mirabilis [GenBank:AB525688]. The finding that traC-dsbC is present in pIP1202, pYR1, pP91278, pP99-018, pMRV150 and pRA1, which lack the CMY island, revealed that this gene cluster is part of a conserved core region of these closely related IncA/C plasmids. However, this region did not match with any other plasmids in the database, and it was not amplified in the CMY- plasmids of ST213 (Figure 2). Therefore, to assess the insertion of the right CMY junction, a second marker was used: PCR D spanning from sugE to the hypothetical protein 0093 (Figure 4). The complete traVA-tnpA right junction (PCR A and B) of the CMY island was identical to that of the E. coli and Newport plasmids, but only traVA (PCR B) was present in the other CMY- IncA/C reference plasmids. This result indicates that this marker is the left CMY island junction. Interestingly, the ST213 CMY- plasmids did not amplify the traVA region, indicating that the region around the CMY island is not present in these plasmids. R-7 and R-8 were found to be present in all the IncA/C reference plasmids, with the only exception being peH4H, which lacks R-7. The mer region was detected only in the E. coli pAR060302 and Newport plasmids; however, it was found to be related to other mer operons present in several plasmids such as pRMH760 (Klebsiella pneumoniae).
Characterization of the CMY region
When we started this study, the only completely sequenced plasmid carrying blaCMY-2 was that of the Newport strain [GenBank:NC_009140] . PCR mapping experiments were performed to compare the CMY region of our Typhimurium isolates with that of Newport pSN254 (Figure 4 and Additional file 1, Table S1). To determine if the blaCMY-2 gene is present as an inverted repeat element as in pSN245, we performed PCR H and I, which we expected to produce bands of around 3.2 and 2.3 kb, respectively, based on the in silico prediction. The Newport strain SN11 was used as a positive control for these amplifications. No bands were obtained with our Typhimurium isolates, consistent with the notion that our isolates possess only a single blaCMY-2 gene. We designed a set of primer pairs to amplify overlapping fragments covering the complete CMY region and to obtain the nucleotide sequence of one of our isolates, YUHS 07-18, which is the most recent strain in our collection and which displays XbaI and PstI fingerprints prevalent in the ST213 population. The 12,621-bp sequence of YUHS07-18 [GenBank:HQ203988] spanning from traV to traC was found to be identical to the corresponding region of pSN254 [GenBank:NC_009140] , and it has the same CMY region configuration as the E. coli plasmid pAR060302 [GenBank:FJ621588] .
Southern blot hybridization of PstI plasmid restriction fingerprints
Conjugative transfer of IncA/C plasmids
Ten CMY+ and seven CMY- ST213 isolates were evaluated for conjugative transfer of their A/C plasmids to E. coli DH5α. Transconjugants were only obtained for the CMY+ strain YUHS 05-78 and at a very low frequency (10-7 to 10-9), but they were positive for all nine PCR markers of the donor plasmid, which lacked the mer region (Figure 2). However, no transconjugants were observed when an E. coli strain carrying the YUHS 05-78 CMY+ plasmid was used as the donor. The highest efficiencies were obtained with a donor:recipient ratio of 1:10 and an incubation for 18 hr on a solid medium (see Methods). In our hands, conjugation efficiencies for AR060302 and SN11 strains were in the order of 10-5 and 10-6, respectively. Nevertheless, these frequencies were lower than those reported for these plasmids (i.e. 10-3) [6, 22].
Distribution of IncA/C plasmids within Typhimurium genotypes and across geographic regions
We found an association between the Typhimurium ST213 genotype and large IncA/C plasmids. These plasmids accounted for most of the MDR phenotypes of the strains, and they might be related to the ecological success of this recently emerging clone in Mexico. In a previous study, we reported a trend towards the replacement of the founder ST19 by the derived ST213 in four regions of Mexico. We suggested that the carriage of blaCMY-2 by some of the ST213 strains could only partially explain their increased prevalence because half of the ST213 strains do not harbour blaCMY-2. In the present study, we discovered that the CMY- strains also harbour large IncA/C plasmids with several resistance determinants. The lack of pSTV and the carriage of IncA/C plasmids are remarkable features of the ST213 genotype in the Mexican Typhimurium population. We speculate that ST213 arose as a clone lacking pSTV and that this condition allowed the acquisition of the large IncA/C plasmids. The success of this association could be due to antimicrobial pressure exerted by human clinical and animal-production practices on the Typhimurium population.
We previously detected several associations among chromosomal genotypes and accessory genes , suggesting that the population subgroups generated by these associations could be explained by several evolutionary processes, such as barriers to genetic exchange, genetic drift or recent clonal expansions within the Typhimurium population. The present study reveals the tight association between the ST213 genotype and IncA/C plasmids. Associations between plasmid type and chromosomal genotype have been reported for other Salmonella serovars, such as Newport [24, 25] and Typhi . Daniels et al.  described the relationship between Newport and its plasmids as clonal based on the model proposed by Souza and Eguiarte , implying that strong co-evolution may be occurring between the plasmid and the host, with very limited plasmid transfer among bacteria.
The plasmid types appear to cluster geographically. All the Yucatán isolates carry type I plasmids, while all the isolates from Sonora carry only type II plasmids. Isolates from Michoacán and San Luis Potosí harbour plasmids from both types I (CMY+ and CMY-) and II. These patterns demonstrate a distribution gradient of the IncA/C plasmids from the northern (Sonora) to the southern (Yucatán) part of Mexico, with intermediate levels in the middle part of Mexico (Michoacán and San Luis Potosí). This gradient is also related to the higher number of resistances conferred by the type I plasmids than by the CMY- type II plasmids (>6 vs. <6, respectively; Figure 2). These trends provide information for understanding the ecology and epidemiology of the emergent ST213 genotype in Mexico, and they increase our knowledge of the evolution of MDR in Typhimurium.
Mobility of the ST213 IncA/C plasmids
The conjugation frequencies reported for IncA/C CMY+ plasmids are highly variable. Welch et al.  reported a lack of transferability for the Newport IncA/C plasmids, while Poole et al.  observed conjugation frequencies between 10-2 and 10-5, but only when other replicons were present and co-transferred. On the other hand, most studies have reported that Typhimurium plasmids are non-conjugative [23, 27] or transfer at moderate frequencies (10-3 to 10-7) . In the present study, we found that only one of the IncA/C plasmids tested was able to conjugate, albeit at very low frequencies (10-7 to10-9). The only distinctive feature of this YUHS 05-78, 150 kb CMY+ plasmid is its lack of the mer region. It has been suggested that the inability of Salmonella CMY+ plasmids to conjugate is due to the insertion of the CMY island into the tra operon on the plasmid backbone . However, the conjugative plasmid YUHS 05-78 has the CMY island inserted in between traA and traC, and this is also true for almost all the other CMY+ plasmids. We think that the reduced conjugative ability of the IncA/C plasmids in Salmonella might be due to chromosomally encoded factors, such as the thickness of the cell envelope, rather than to plasmid-encoded features, or it may depend on the presence of additional helper plasmids, as previously suggested [5, 8]. The predominant lack of conjugation ability of our IncA/C plasmids agrees with the clonal dissemination trend detected between chromosomal backgrounds and plasmid patterns, as revealed by XbaI and PstI digests (Figure 2), respectively. This study provides evidence of frequent rearrangements shaping the genetic composition of the IncA/C plasmids harboured by ST213 strains. It is possible that the IncA/C plasmids circulating in Typhimurium were acquired from other Salmonella serotypes or other enteric bacteria such as E. coli. The higher plasmid diversity and conjugation frequencies of E. coli in comparison with Salmonella led Daniels et al.  to speculate that insertions and deletions that occur during promiscuous plasmid sharing among E. coli isolates occasionally result in plasmids that are successful in Salmonella. It is possible that this is the scenario in Mexico, where resistance to ceftriaxone was detected in E. coli several years prior to that in Salmonella (M. Zaidi, unpublished data).
Evolutionary origin of the two IncA/C types
The combined results of the PCR screening and the nucleotide sequence analysis suggest that the IncA/C plasmids from types I and II have a recent common origin and are evolving by the insertion/deletion of DNA stretches rather than by point mutations, in agreement with the conclusions derived from other studies [5, 6, 8, 10]. For example, in this study, insertion of the IP-1 integron (dfrA12, orfF and aadA2) and deletion of the R-8 segment were observed in most of the CMY+ plasmids.
The PCR markers and plasmid sizes of the IncA/C CMY+ reference plasmids of E. coli AR060302  and Newport SN11  corresponded with those of our Typhimurium IncA/C CMY+ plasmids. However, their PstI restriction profiles were related to type II plasmids, which included most of our Typhimurium IncA/C CMY- plasmids (Figure 2). As the CMY+ reference plasmids and our type II plasmids were found to be similar, we speculate that the ST213 IncA/C CMY+ plasmids diversified from a type II ancestor by the insertion and deletion of DNA segments such as R-8 and the IP-1 integron, among others. Likewise, hybridization assays showed that this integron mapped to some of the bands that are absent in the type II restriction profiles (Figure 5). Despite the nucleotide identity of the sequenced regions of the CMY- plasmids, and aside from IP-1, they share only three of the ten genetic markers (repA, floR and mer; Figure 2 and Figure 3) that have been used to study the IncA/C plasmids, indicating that they belong to an IncA/C plasmid lineage that has not been thoroughly studied yet. The floR allele of the CMY+ and CMY- plasmids was identical to that of pSN254, but the CMY region of the CMY+ plasmids was identical to the region of pAR060302, suggesting a mosaic pattern of ancestry with plasmids from other Salmonella serovars and E. coli. Moreover, the type II CMY- plasmids were found to be smaller (100 vs. 150-160 kb; Figure 2), consistent with the notion that the CMY+ plasmids are the result of the insertion of DNA modules into a type II precursor plasmid. A formal alternative would be that a substantial loss of DNA fragments originally present in the CMY+ plasmids occurred, giving raise to ST213 type II derivatives. In this respect, it would be necessary to obtain the full sequence of some of our CMY+ and CMY- plasmids to identify their genetic compositions and to unravel their evolutionary histories.
The ecological success of the newly emerging Typhimurium ST213 genotype may be related to the carriage of IncA/C plasmids. Two divergent genetic types of IncA/C plasmids were identified. Type I plasmids are the most abundant and widespread; their genetic compositions are similar to those of other reported IncA/C plasmids. Type II plasmids display a lower number of PstI restriction fragments and are smaller than type I plasmids. Only three of the ten plasmid regions analyzed were detected in type II plasmids, even though the nucleotide sequences for these regions were identical for both types. We conclude that type I and II plasmids originated from a common ancestor and that the insertion and deletion of DNA stretches have shaped their evolutionary histories.
Typhimurium ST213 isolates
The isolates used in the present study were described in a previous publication . Briefly, the isolates were collected from a Mexican surveillance network . The predominant ST213 genotype formed a well-defined group in the dendrogram based on XbaI fingerprints (named cluster I), which was subdivided into subclusters Ia, Ib and Ic. The ST213 genotype was associated with the plasmid-borne blaCMY-2 gene conferring resistance to extended spectrum cephalosporins and with the integron profile one (IP-1) carrying an array of three cassettes containing the genes dfr12, orfF and aadA2 conferring resistance to trimethoprim and streptomycin. These accessory elements were not present in all the isolates: among the 68 ST213 isolates, 31 lacked blaCMY-2, 19 did not have IP-1 and 12 lacked both of them. In the present study, a representative sample of 45 isolates was chosen to characterize their IncA/C plasmids. The code labels of the strains were designed to include relevant information about their isolation. The first two letters indicate the state: YU, Yucatán; SL, San Luis Potosí; MI, Michoacán; and SO, Sonora. The third and fourth letters indicate the isolation source: HS, human; PUS, pork meat; RES, beef meat; POLS, chicken meat; RAPUS, pork intestine; and RARES, beef intestine. The first two numbers indicate the year of isolation (from 2002-2007), and the last numbers are the isolate numbers.
Plasmid DNA extraction and plasmid profiles
Plasmid profiles were obtained by a modified alkaline lysis procedure  and were visualized by electrophoresis in 0.7% agarose gels subjected to 60 V for 8 hours. Plasmid profiles of E. coli V157 , E. coli E2348/69  and E. coli AR060302  were used as molecular markers for large plasmids, and supercoiled DNA ladders (Invitrogen) were used for smaller plasmids. To resolve plasmids larger than 50 kb, we performed S1 restriction PFGE. Briefly, total DNA was embedded in agarose plugs, and slices were treated with 8 U of nuclease S1 (Promega) at 37°C for 45 min. The PFGE running conditions were 6 V/Cm at 14°C for 15 hours, and switching times ranged from 1 sec to 25 sec. The Low Range PFG Marker was used as the reference standard (New England Biolabs).
Plasmid transformation and antimicrobial susceptibility testing
Plasmid DNA was introduced into E. coli DH5α and TOP10 through electroporation. Transformants were selected on Luria-Bertani (LB) agar containing either 2-μg/ml ceftriaxone for the CMY+ isolates or 15-μg/ml chloramphenicol for the CMY- isolates.
Susceptibility testing was performed by disk diffusion according to Clinical and Laboratory Standards Institute (CLSI) recommendations . The following commercially purchased disks (Becton, Dickinson and Company, Sparks, MD, USA) were used: ampicillin (A), 10 μg; chloramphenicol (C), 30 μg; streptomycin (S), 10 μg; sulfonamides (Su), 250 μg; tetracycline (T), 30 μg; ceftriaxone (Ax), 30 μg; gentamicin (G), 10 μg; trimethoprim-sulfamethoxazole (Sxt), 1.25/23.75 μg; kanamycin (K), 10 μg; nalidixic acid (N), 30 μg. Resistance to ceftriaxone was confirmed by agar dilution using a breakpoint of ≥4 μg/ml.
Plasmid PstI restriction and Southern hybridization
Plasmid restriction analysis with PstI has been used for the classification of CMY+ plasmids according to Giles types [12, 20]. Giles type A has been correlated with IncA/C plasmids carrying a single blaCMY-2 copy, type B with IncI1 plasmids, and type C with IncA/C plasmids carrying two blaCMY-2 copies [6, 19]. Plasmid DNA was treated with 15 U of PstI (Invitrogen) at 37°C for 6 hours and was electrophoresed in 0.7% agarose for 3 hours at 100 V. The PstI digests were transferred to positively charged membranes (Amersham Hybond™ - N+) and were hybridized with blaCMY-2, repA, floR, merA-T and dfr12-orfF PCR products labeled with α-32P-dCTP by standard methods . Hybridizations were carried out at 65°C.
To determine the genetic relationship between the IncA/C plasmids, PstI restriction profiles were analyzed with GelComparII. Clustering was performed using the UPGMA algorithm based on Dice coefficients. One reference isolate was run on all gels. A stringency parameter of 1.0% band position tolerance was used since this was the point at which the common restriction profile was identical across gels.
PCR assays and nucleotide sequencing
The complete list of primers used in this study is shown in Additional file 1, Table S1. To determine the incompatibility groups of the plasmids, PCR-replicon typing for the Salmonella isolates and their E. coli transformants was performed using the primers and conditions recommended by Carattoli et al. . The incompatibility groups tested were IncA/C, FII, HI1, HI2 and I1.
The E. coli transformants carrying the IncA/C plasmids were screened by PCR using primers to detect seven regions distributed throughout the reported IncA/C plasmids [5–8, 10] (Figure 3). The primers used are listed in Additional file 1, Table S1, and for a detailed explanation see the legend to Figure 3. The nucleotide sequences of these regions were determined for a representative sample of ten isolates (Additional file 2, Table S2) using the same primers and conditions. Plasmid DNA of the transformants was used for PCR mapping of the CMY island and surrounding regions. Overlapping PCR assays were designed to cover the CMY region using primers previously published  or designed by us based on the reported sequence of pSN254 [GenBank:NC_009140] . Nine reactions were designed to determine the configuration at the CMY region (Figure 4, PCRs A-I). PCRs A, B, D and G were included in the plasmid PCR screening scheme to examine the CMY junction of all isolates. The nucleotide sequence for the 12,563 bp CMY region was generated for isolate YUHS 07-18 [GenBank:HQ203988], which was the most recent representative isolate of ST213. Accession numbers of the nucleotide sequences generated for representative strains (Additional file 2, Table S2) are as follows: repA/C [GenBank: HQ203980], floR [GenBank: HQ203981], PCR G [GenBank: HQ203982], PCR A [GenBank: HQ203983], R-7 [GenBank: HQ203984], R-8 [GenBank: HQ203985], and two mer alleles [GenBank: HQ203986] and [GenBank: HQ203987]. All nucleotide sequences were compared against public databases using the BLAST algorithm at NCBI .
We performed conjugation experiments for 17 Typhimurium isolates using a rifampicin (100 μg/ml)-resistant derivative of E. coli DH5α as the recipient. We tested several conditions for the conjugation experiments, including a liquid versus solid LB medium, presence of absence of filters, two incubation temperatures (37 and 42°C), several incubation times (from 3 to 48 hrs) and different donor:recipient ratios (1:1, 1:2, 1:5 and 1:10). Conjugations were performed using both the Salmonella isolates and their respective E. coli transformants. Ceftriaxone (2 μg/ml) and chloramphenicol (15 μg/ml) were used to select for the transfer of CMY+ and CMY- plasmids, respectively. Transfer efficiencies were calculated as the number of transconjugants per donor.
This work was partially funded by research grants from CONACyT/Mexico (No.82383 and No. 60227) and DGAPA/UNAM (No. 216310 and 205107) to EC and Ricardo Oropeza; by a Ph.D. fellowship from CONACyT (No. 214945) to MW; and by a postdoctoral fellowship to CS from CONACyT (No. 60796).
We are grateful to all the people that kindly supplied reference strains: E. coli V157 was provided by Francis L. Macrina, E. coli AR060302 was provided by Douglas R. Call, Newport SN11 was provided by Toni L. Poole and Dayna Harhay, and E. coli E2348/69 was provided by Alejandro Huerta. We appreciate the technical assistance of Elvira Villa; the administrative support of Amapola Blanco and Rosalva González; and the primer synthesis and sequencing service given by Eugenio López, Santiago Becerra, Paul Gaytán and Jorge Yañez at the Instituto de Biotecnología, UNAM. Rafael Díaz (CCG, UNAM) and Cindy Dierikx (Central Veterinary Institute, the Netherlands) helped us with the S1 PFGE protocol.
- Levin BR, Bergstrom CT: Bacteria are different: observations, interpretations, speculations, and opinions about the mechanisms of adaptive evolution in prokaryotes. Proc Natl Acad Sci USA. 2000, 97: 6981-6985. 10.1073/pnas.97.13.6981.PubMedPubMed CentralView ArticleGoogle Scholar
- Heuer H, Abdo Z, Smalla K: Patchy distribution of flexible genetic elements in bacterial populations mediates robustness to environmental uncertainty. FEMS Microbiol Ecol. 2008, 65: 361-371. 10.1111/j.1574-6941.2008.00539.x.PubMedView ArticleGoogle Scholar
- Souza V, Eguiarte LE: Bacteria gone native vs. bacteria gone awry?: plasmidic transfer and bacterial evolution. Proc Natl Acad Sci USA. 1997, 94: 5501-5503. 10.1073/pnas.94.11.5501.PubMedPubMed CentralView ArticleGoogle Scholar
- Couturier M, Bex F, Bergquist P, Maas WK: Identification and classification of bacterial plasmids. Microbiol Rev. 1988, 52: 375-395.PubMedPubMed CentralGoogle Scholar
- Fricke WF, Welch TJ, McDermott PF, Mammel MK, LeClerc JE, White DG, Cebula TA, Ravel J: Comparative genomics of the IncA/C multidrug resistance plasmid family. J Bacteriol. 2009, 191: 4750-4757. 10.1128/JB.00189-09.PubMedPubMed CentralView ArticleGoogle Scholar
- Call DR, Singer RS, Meng D, Broschat SL, Orfe LH, Anderson JM, Herndon DR, Kappmeyer LS, Daniels JB, Besser TE: blaCMY-2-positive IncA/C plasmids from Escherichia coli and Salmonella enterica are a distinct component of a larger lineage of plasmids. Antimicrob Agents Chemother. 2010, 54: 590-596. 10.1128/AAC.00055-09.PubMedPubMed CentralView ArticleGoogle Scholar
- McIntosh D, Cunningham M, Ji B, Fekete FA, Parry EM, Clark SE, Zalinger ZB, Gilg IC, Danner GR, Johnson KA, et al: Transferable, multiple antibiotic and mercury resistance in Atlantic Canadian isolates of Aeromonas salmonicida subsp. salmonicida is associated with carriage of an IncA/C plasmid similar to the Salmonella enterica plasmid pSN254. J Antimicrob Chemother. 2008, 61: 1221-1228. 10.1093/jac/dkn123.PubMedPubMed CentralView ArticleGoogle Scholar
- Welch TJ, Fricke WF, McDermott PF, White DG, Rosso ML, Rasko DA, Mammel MK, Eppinger M, Rosovitz MJ, Wagner D, et al: Multiple antimicrobial resistance in plague: an emerging public health risk. PLoS ONE. 2007, 2: e309-10.1371/journal.pone.0000309.PubMedPubMed CentralView ArticleGoogle Scholar
- Pan JC, Ye R, Wang HQ, Xiang HQ, Zhang W, Yu XF, Meng DM, He ZS: Vibrio cholerae O139 multiple-drug resistance mediated by Yersinia pestis pIP1202-like conjugative plasmids. Antimicrob Agents Chemother. 2008, 52: 3829-3836. 10.1128/AAC.00375-08.PubMedPubMed CentralView ArticleGoogle Scholar
- Kim MJ, Hirono I, Kurokawa K, Maki T, Hawke J, Kondo H, Santos MD, Aoki T: Complete DNA sequence and analysis of the transferable multiple-drug resistance plasmids (R Plasmids) from Photobacterium damselae subsp. piscicida isolates collected in Japan and the United States. Antimicrob Agents Chemother. 2008, 52: 606-611. 10.1128/AAC.01216-07.PubMedPubMed CentralView ArticleGoogle Scholar
- Bauernfeind A, Stemplinger I, Jungwirth R, Giamarellou H: Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance. Antimicrob Agents Chemother. 1996, 40: 221-224.PubMedPubMed CentralGoogle Scholar
- Carattoli A, Tosini F, Giles WP, Rupp ME, Hinrichs SH, Angulo FJ, Barrett TJ, Fey PD: Characterization of plasmids carrying CMY-2 from expanded-spectrum cephalosporin-resistant Salmonella strains isolated in the United States between 1996 and 1998. Antimicrob Agents Chemother. 2002, 46: 1269-1272. 10.1128/AAC.46.5.1269-1272.2002.PubMedPubMed CentralView ArticleGoogle Scholar
- Zhao S, White DG, McDermott PF, Friedman S, English L, Ayers S, Meng J, Maurer JJ, Holland R, Walker RD: Identification and expression of cephamycinase bla(CMY) genes in Escherichia coli and Salmonella isolates from food animals and ground meat. Antimicrob Agents Chemother. 2001, 45: 3647-3650. 10.1128/AAC.45.12.3647-3650.2001.PubMedPubMed CentralView ArticleGoogle Scholar
- Hopkins KL, Liebana E, Villa L, Batchelor M, Threlfall EJ, Carattoli A: Replicon typing of plasmids carrying CTX-M or CMY beta-lactamases circulating among Salmonella and Escherichia coli isolates. Antimicrob Agents Chemother. 2006, 50: 3203-3206. 10.1128/AAC.00149-06.PubMedPubMed CentralView ArticleGoogle Scholar
- Lindsey RL, Fedorka-Cray PJ, Frye JG, Meinersmann RJ: Inc A/C plasmids are prevalent in multidrug-resistant Salmonella enterica isolates. Appl Environ Microbiol. 2009, 75: 1908-1915. 10.1128/AEM.02228-08.PubMedPubMed CentralView ArticleGoogle Scholar
- Wiesner M, Zaidi MB, Calva E, Fernandez-Mora M, Calva JJ, Silva C: Association of virulence plasmid and antibiotic resistance determinants with chromosomal multilocus genotypes in Mexican Salmonella enterica serovar Typhimurium strains. BMC Microbiol. 2009, 9: 131-10.1186/1471-2180-9-131.PubMedPubMed CentralView ArticleGoogle Scholar
- Salmonella MLST database. [http://mlst.ucc.ie/mlst/dbs/Senterica]
- Zaidi MB, Leon V, Canche C, Perez C, Zhao S, Hubert SK, Abbott J, Blickenstaff K, McDermott PF: Rapid and widespread dissemination of multidrug-resistant blaCMY-2 Salmonella Typhimurium in Mexico. J Antimicrob Chemother. 2007, 60: 398-401. 10.1093/jac/dkm168.PubMedView ArticleGoogle Scholar
- Carattoli A, Miriagou V, Bertini A, Loli A, Colinon C, Villa L, Whichard JM, Rossolini GM: Replicon typing of plasmids encoding resistance to newer beta-lactams. Emerg Infect Dis. 2006, 12: 1145-1148.PubMedPubMed CentralView ArticleGoogle Scholar
- Giles WP, Benson AK, Olson ME, Hutkins RW, Whichard JM, Winokur PL, Fey PD: DNA sequence analysis of regions surrounding blaCMY-2 from multiple Salmonella plasmid backbones. Antimicrob Agents Chemother. 2004, 48: 2845-2852. 10.1128/AAC.48.8.2845-2852.2004.PubMedPubMed CentralView ArticleGoogle Scholar
- Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ: Identification of plasmids by PCR-based replicon typing. J Microbiol Methods. 2005, 63: 219-228. 10.1016/j.mimet.2005.03.018.PubMedView ArticleGoogle Scholar
- Poole TL, Edrington TS, Brichta-Harhay DM, Carattoli A, Anderson RC, Nisbet DJ: Conjugative Transferability of the A/C Plasmids from Salmonella enterica Isolates That Possess or Lack bla(CMY) in the A/C Plasmid Backbone. Foodborne Pathog Dis. 2009, 1185-1194. 10.1089/fpd.2009.0316.Google Scholar
- Winokur PL, Brueggemann A, DeSalvo DL, Hoffmann L, Apley MD, Uhlenhopp EK, Pfaller MA, Doern GV: Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase. Antimicrob Agents Chemother. 2000, 44: 2777-2783. 10.1128/AAC.44.10.2777-2783.2000.PubMedPubMed CentralView ArticleGoogle Scholar
- Zhao S, McDermott PF, Friedman S, Abbott J, Ayers S, Glenn A, Hall-Robinson E, Hubert SK, Harbottle H, Walker RD, et al: Antimicrobial resistance and genetic relatedness among Salmonella from retail foods of animal origin: NARMS retail meat surveillance. Foodborne Pathog Dis. 2006, 3: 106-117. 10.1089/fpd.2006.3.106.PubMedView ArticleGoogle Scholar
- Daniels JB, Call DR, Besser TE: Molecular epidemiology of blaCMY-2 plasmids carried by Salmonella enterica and Escherichia coli isolates from cattle in the Pacific Northwest. Appl Environ Microbiol. 2007, 73: 8005-8011. 10.1128/AEM.01325-07.PubMedPubMed CentralView ArticleGoogle Scholar
- Phan MD, Kidgell C, Nair S, Holt KE, Turner AK, Hinds J, Butcher P, Cooke FJ, Thomson NR, Titball R, et al: Variation in Salmonella enterica serovar typhi IncHI1 plasmids during the global spread of resistant typhoid fever. Antimicrob Agents Chemother. 2009, 53: 716-727. 10.1128/AAC.00645-08.PubMedPubMed CentralView ArticleGoogle Scholar
- Su LH, Chen HL, Chia JH, Liu SY, Chu C, Wu TL, Chiu CH: Distribution of a transposon-like element carrying bla(CMY-2) among Salmonella and other Enterobacteriaceae. J Antimicrob Chemother. 2006, 57: 424-429. 10.1093/jac/dki478.PubMedView ArticleGoogle Scholar
- Zaidi MB, Calva JJ, Estrada-Garcia MT, Leon V, Vazquez G, Figueroa G, Lopez E, Contreras J, Abbott J, Zhao S, et al: Integrated food chain surveillance system for Salmonella spp. in Mexico. Emerg Infect Dis. 2008, 14: 429-435. 10.3201/eid1403.071057.PubMedPubMed CentralView ArticleGoogle Scholar
- Sambrook J, Russell DW: Molecular cloning. A laboratory manual. 2001, New York: Cold Spring Harbor Laboratory Press, ThirdGoogle Scholar
- Macrina FL, Kopecko DJ, Jones KR, Ayers DJ, McCowen SM: A multiple plasmid-containing Escherichia coli strain: convenient source of size reference plasmid molecules. Plasmid. 1978, 1: 417-420. 10.1016/0147-619X(78)90056-2.PubMedView ArticleGoogle Scholar
- Iguchi A, Thomson NR, Ogura Y, Saunders D, Ooka T, Henderson IR, Harris D, Asadulghani M, Kurokawa K, Dean P, et al: Complete genome sequence and comparative genome analysis of enteropathogenic Escherichia coli O127:H6 strain E2348/69. J Bacteriol. 2009, 191: 347-354. 10.1128/JB.01238-08.PubMedPubMed CentralView ArticleGoogle Scholar
- NCCLS: Performance Standards for Antimicrobial Disk Susceptibility Tests; Document M2-A7. Book Performance Standards for Antimicrobial Disk Susceptibility Tests; Document M2-A7 (Editor ed.^eds.), Approved Standard-Seventh Edition edition. City. 2000Google Scholar
- Kang MS, Besser TE, Call DR: Variability in the region downstream of the blaCMY-2 beta-lactamase gene in Escherichia coli and Salmonella enterica plasmids. Antimicrob Agents Chemother. 2006, 50: 1590-1593. 10.1128/AAC.50.4.1590-1593.2006.PubMedPubMed CentralView ArticleGoogle Scholar
- National Center for Biotechnology Information. [http://www.ncbi.nlm.nih.gov]
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.